Associations Between Antiretroviral Regimen and Changes in Blood Pressure: Results From the D2EFT Study.

ABSTRACT: In this randomized controlled study, individuals taking dolutegravir+darunavir/ritonavir had greater increases in systolic and diastolic blood pressure than those taking 2 nucleoside reverse-transcriptase inhibitors+darunavir/ritonavir at week-48. The difference remained significant after controlling for confounding factors, including weight gain.

SUBMITTER: Nyein PP 

PROVIDER: S-EPMC11797029 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature